1-Bromo-2-methylpropane → HCID 22951240, compound
Reaction equation
[CH3:1][C:2]1[CH:7]=[C:6]([N+:8]([O-:10])=[O:9])[CH:5]=[CH:4][C:3]=1[N:11]=[C:12]1[NH:16][C@@H:15]([C@H:17]([O:19][C:20]([CH3:23])([CH3:22])[CH3:21])[CH3:18])[CH2:14][S:13]1.[CH2:24](Br)[CH:25]([CH3:27])[CH3:26]>>[C:20]([O:19][C@@H:17]([C@H:15]1[CH2:14][S:13][C:12](=[N:11][C:3]2[CH:4]=[CH:5][C:6]([N+:8]([O-:10])=[O:9])=[CH:7][C:2]=2[CH3:1])[N:16]1[CH2:24][CH:25]([CH3:27])[CH3:26])[CH3:18])([CH3:22])([CH3:21])[CH3:23]Participants
3
Procedure
(1R,2R)-1-(Methanesulfonyloxymethyl)-2-(tert-butoxy)propanammonium chloride (Method B8a; 1.5 g, 5.5 mmol) was reacted with 2-methyl-4-nitrophenyl isothiocyanate in a manner analogous to that described in Method C1a to afford 4(S)-(1(R)-tert-butoxyethyl)-2-(2-methyl-4-nitrophenylimino)-1,3-thiazolidine (1.2 g, 67%). The (4S)-2-(2-methyl-4-nitrophenylimino)-4-(1(R)-tert-butoxyethyl)-1,3-thiazolidine was reacted with isobutyl bromide in a manner analogous to Method D2a to yield (4S)-4-(1(R)-tert-butoxyethyl)-3-isobutyl-2-(2-methyl-4-nitrophenylimino)-1,3-thiazolidine (0.26 g, 56%): TLC (25% EtOAc/hex) Rf0.67.
Sources & evidence
- ORD record
- ord-8c17090c93fe4b95b849c116c693a280
- Source dataset
- uspto-grants-2002_03
- Patent number
- US06353006B1
Reaction notes
Loading…